The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets
Cancer Cell · 2025-07 · 43 (7) · 1328-1346.e8
DOI: 10.1016/j.ccell.2025.05.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-07. Verfasst von Jaco C Knol und 47 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Ne…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Proteome, Proteomics. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 132 Literaturangaben. Gefördert von: KWF Kankerbestrijding, Key Technologies Research and Development Program, Netherlands eScience Center.
Abstract (Originalsprache)
Most cancer proteomics studies to date have focused on a single cancer type. We report The Pan-Cancer Proteome Atlas (TPCPA) based on data-independent acquisition mass spectrometry, to better understand cancer biology and identify therapeutic targets and biomarkers. TPCPA includes 9,670 proteins derived from 999 primary tumors representing 22 cancer types. We describe pan-cancer and cancer type-enriched proteins with extensive external annotation, prioritizing candidate drug targets and biomarkers. Relevant for proteolysis-targeting chimeras, we identify E3-ubiquitin ligases highly expressed in specific tumor types, including HERC5 (esophageal cancer) and RNF5 (liver cancer). Co-expression analysis reveals 13 modules, including unexpected hub proteins as potential drug targets (e.g., GFPT1, LRPPRC, PINK1, DOCK2, and PTPN6). Analysis of 195 colorectal cancers identifies protein markers for RNA-based consensus molecular subtypes (CMSs) and two immune subtypes with prognostic value. We report a cancer type classifier for identification of cancers of unknown primary origin. All TPCPA data can be queried in a dedicated web resource.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam,…
- School of Medicine, Westlake University, Hangzhou, Zhejiang, China; Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
- School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurosurgery, De Boelelaan 1117, Amsterdam, the Netherlands.
- Medizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.
- Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
Förderung
- KWF Kankerbestrijding
- Key Technologies Research and Development Program
- Netherlands eScience Center
- Dutch Research Council
- National Key Research and Development Program of China
- Cancer Centre Amsterdam
Zitieren
APA
Knol, J. C., Lyu, M., Böttger, F., Nunes Monteiro, M., Pham, T. V., Rolfs, F., Vallés-Martí, A., Schelfhorst, T., de Goeij-de Haas, R. R., Bijnsdorp, I. V., Wang, S., Zhang, F., A, J., Westerman, B. A., Sitek, B., Lehtiö, J., Koster, J., IJzermans, J. N. M., van Laarhoven, H. W. M., …, & Jimenez, C. R. (2025). The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets. Cancer Cell, 43(7), 1328-1346.e8. https://doi.org/10.1016/j.ccell.2025.05.003
Vancouver
Knol JC, Lyu M, Böttger F, Nunes Monteiro M, Pham TV, Rolfs F, et al. The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets. Cancer Cell. 2025;43(7):1328-1346.e8. doi:10.1016/j.ccell.2025.05.003
BibTeX
@article{Knol2025,
author = {Knol, Jaco C and Lyu, Mengge and Böttger, Franziska and Nunes Monteiro, Madalena and Pham, Thang V and Rolfs, Frank and Vallés-Martí, Andrea and Schelfhorst, Tim and de Goeij-de Haas, Richard R and Bijnsdorp, Irene V and Wang, Shuaiyao and Zhang, Fangfei and A, Jun and Westerman, Bart A and Sitek, Barbara and Lehtiö, Janne and Koster, Jan and IJzermans, Jan N M and van Laarhoven, Hanneke W M and Bijlsma, Maarten F and Medema, Jan Paul and Henneman, Alex A and Piersma, Sander R and Brakenhoff, Ruud H and Cloos, Jacqueline and Cordo', Valentina and de Jong, Daphne and Kazemier, Geert and Koppers-Lalic, Danijela and Labots, Mariette and Le Large, Tessa Y S and Martens, John W M and Meijerink, Jules P P and Mumtaz, Madiha and Scheepbouwer, Chantal and Kibbelaar, Robby E and Noske, David P and Steenbergen, Renske D M and van Grieken, Nicole C T and van Houdt, Winan and Giovannetti, Elisa and van Leenders, Geert J L H and Jonkers, Jos and Liu, Tong and Yan, Meisi and Zhan, Xiaolu and Guo, Tiannan and Jimenez, Connie R},
title = {The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {7},
pages = {1328--1346.e8},
doi = {10.1016/j.ccell.2025.05.003}
}
EUVIMED